Guillain-Barré Syndrome ‘More Common Than Expected’ in Early RSV Vaccine Trial
![Guillain-Barré Syndrome ‘More Common Than Expected’ in Early RSV Vaccine Trial Guillain-Barré Syndrome ‘More Common Than Expected’ in Early RSV Vaccine Trial](https://thevaccinereaction.org/wp-content/uploads/2024/06/GBS1.png)
Reports of the nervous system disorder Guillain-Barré syndrome (GBS) were “more common than expected” in the older adult population who received the new vaccine for respiratory syncytial virus (RSV). The data, reported by the U.S. Centers for Disease Control and Prevention (CDC), matched trial data reported earlier this year.1 GBS is a “polio-like” inflammatory autoimmune […]
New Study Documents COVID-19 Vaccine Harms—Low Platelets, GBS, Myocarditis
![New Study Documents COVID-19 Vaccine Harms—Low Platelets, GBS, Myocarditis New Study Documents COVID-19 Vaccine Harms—Low Platelets, GBS, Myocarditis](https://img.youtube.com/vi/U3dxOzpQXYg/maxresdefault.jpg)
There’s a new paper out now in the journal Vaccine, and it’s about the COVID-19 vaccine and some of the harms due to the vaccine. It’s the largest observational analysis of 99 million people, and it’s entitled “COVID-19 Vaccines and Adverse Events of Special Interest: A Multinational Global Vaccine Data Network Cohort Study of 99 […]
Unknown Risks of COVID Shot Harm Revealed in New Report
![Unknown Risks of COVID Shot Harm Revealed in New Report Unknown Risks of COVID Shot Harm Revealed in New Report](https://thevaccinereaction.org/wp-content/uploads/2024/05/chest-pain-1024x433.png)
At the request of the Health Resources Services Administration (HRSA), an agency in the U.S. Department of Health and Human Services (DHHS), the National Academies of Science, Engineering and Medicine assembled a committee of physicians and scientists to conduct a review of the evidence that COVID-19 shots can cause serious harm to health. The evidence […]
CDC Pushes Pfizer’s Pentavalent Meningococcal Vaccine
![CDC Pushes Pfizer’s Pentavalent Meningococcal Vaccine CDC Pushes Pfizer’s Pentavalent Meningococcal Vaccine](https://thevaccinereaction.org/wp-content/uploads/2024/04/Penbraya-1024x682.png)
On Oct. 20, 2023, Pfizer, Inc. announced that the U.S. Food and Drug Administration (FDA) approved its new pentavalent meningococcal vaccine, Penbraya, which targets five meningococcal serogroups (A, B, C, W and Y) that most commonly cause meningococcal disease in adolescents and young adults 10-25 years old. Penbraya, is recommended to be given in two […]
RSV Vaccines for Senior Adults Linked to Guillain-Barré Syndrome
![RSV Vaccines for Senior Adults Linked to Guillain-Barré Syndrome RSV Vaccines for Senior Adults Linked to Guillain-Barré Syndrome](https://thevaccinereaction.org/wp-content/uploads/2024/03/RSV-vaccine-1024x684.png)
On Feb. 29, 2024, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) presented a preliminary analysis that showed that 23 adults over the age of 65 who received a respiratory syncytial virus (RSV) vaccine developed Guillain-Barré syndrome (GBS).1 When a person develops GBS, including after an infection or […]
Some Children Suffered Seizures Following mRNA COVID Shots
![Some Children Suffered Seizures Following mRNA COVID Shots Some Children Suffered Seizures Following mRNA COVID Shots](https://thevaccinereaction.org/wp-content/uploads/2023/07/child.png)
A 2023 analysis published by researchers from Kaiser Permanente and the U.S. Centers for Disease Control and Prevention (CDC) in the journal Pediatrics compared vaccine adverse outcomes following administration of Pfizer/BioNTech’s Comirnaty messenger RNA (mRNA) COVID-19 shot and Moderna/NIAID’s Spikevax mRNA COVID-19 shot among recipients under five years old for a period of 1-21 days […]